Molecular regulation of hepatic dendritic cell function and its relation to liver transplant outcome

Transplantation

Volumn 88, Issue SUPPL. 3, 2009, Pages

  Sumpter, Tina L ^a   Lunz, John G ^a   Demetris, A Jake ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Dendritic cells; Endotoxin tolerance; Liver; Transplant outcome.

Indexed keywords

ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; CELL FUNCTION; CELL MATURATION; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; LEYDIG CELL; LIVER CELL; LIVER GRAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; ENDOTOXINS; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-12; LIVER; LIVER TRANSPLANTATION; MICE; TOLL-LIKE RECEPTOR 10; TOLL-LIKE RECEPTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 70349093145     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181af7c0d     Document Type: Review

References (54)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245.
2. Morelli AE, Thomson AW. Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003; 196: 125.
3. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610.
4. Ochando JC, Homma C, Yang Y, et al. Alloantigen-presenting plasma-cytoid dendritic cells mediate tolerance to vascularized grafts. Nat Im-munol 2006; 7: 652.
5. Lu L, McCaslin D, Starzl TE, et al. Bone marrow-derived dendritic cell progenitors (NLDC 145-, MHC class II-, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60: 1539.
6. Fu F, Li Y, Qian S, et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II-, CD80dim, CD86-) prolong cardiac allo-graft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.
7. Lutz MB, Suri RM, Niimi M, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000; 30: 1813.
8. Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8(-) regulatory T cells in vivo in humans. Blood 2002; 100: 174.
9. Dhodapkar MV, Steinman RM, Krasovsky J, et al. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001; 193: 233.
10. Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002; 195: 695.
11. Moseman EA, Liang X, Dawson AJ, et al. Human plasmacytoid den-dritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4-CD25- regulatory T cells. J Immunol 2004; 173: 4433.
12. De Creus A, Abe M, Lau AH, et al. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005; 174: 2037.
13. Abe M, Tokita D, Raimondi G, et al. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur J Immunol 2006; 36: 2483.
14. Pillarisetty VG, Shah AB, Miller G, et al. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 2004; 172: 1009.
15. Kingham TP, Chaudhry UI, Plitas G, et al. Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 li-gand expansion. Hepatology 2007; 45: 445.
16. Cabillic F, Rougier N, Basset C, et al. Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response. J Hepatol 2006; 44: 552.
17. Khanna A, Morelli AE, Zhong C, et al. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol 2000; 164: 1346.
18. Rastellini C, Lu L, Ricordi C, et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
19. Lau AH, Thomson AW. Dendritic cells and immune regulation in the liver. Gut 2003; 52: 307.
20. Liew FY, Xu D, Brint EK, et al. Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446.
21. Lunz JG III, Specht SM, Murase N, et al. Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 2007; 46: 1946.
22. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7: 179.
23. Honda K, Taniguchi T. IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Im-munol 2006; 6: 644.
24. Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006; 25: 349.
25. Giannoukakis N, Bonham CA, Qian S, et al. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oli-godeoxyribonucleotides. Mol Ther 2000; 1 (5 Pt 1): 430.
26. Bonham CA, Peng L, Liang X, et al. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol 2002; 169: 3382.
27. Xu MQ, Suo YP, Gong JP, et al. Augmented regeneration of partial liver allograft induced by nuclear factor-kappaB decoy oligodeoxynucleotides-modified dendritic cells. World J Gastroenterol 2004; 10: 573.
28. Lian ZX, Okada T, He XS, et al. Heterogeneity of dendritic cells in the mouse liver: Identification and characterization of four distinct populations. J Immunol 2003; 170: 2323.
29. Hamerman JA, Tchao NK, Lowell CA, et al. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 2005; 6: 579.
30. Sjolin H, Robbins SH, Bessou G, et al. DAP12 signaling regulates plas-macytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol 2006; 177: 2908.
31. Divangahi M, Yang T, Kugathasan K, et al. Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J Immunol 2007; 179: 4015.
32. Orabona C, Tomasello E, Fallarino F, et al. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. Eur J Immu-nol 2005; 35: 3111.
33. van 't Veer C, van den Pangaart PS, van Zoelen MA, et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol 2007; 179: 7110.
34. Gautier G, Humbert M, Deauvieau F, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201: 1435.
35. Johnson LM, Scott P. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major. J Immunol 2007; 178: 7259.
36. Hanada T, Tanaka K, Matsumura Y, et al. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol 2005; 174: 4325.
37. Mellor AL, Baban B, Chandler PR, et al. Cutting edge: CpG oligonucle-otides induce splenic CD19- dendritic cells to acquire potent in-doleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol 2005; 175: 5601.
38. Sharma MD, Baban B, Chandler P, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 2007; 117: 2570.
39. Lin YC, Chen CL, Nakano T, et al. Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance. J Gastro-enterol Hepatol 2008; 23 (7 Pt 2): e243.
40. Laurence JM, Wang C, Park ET, et al. Blocking indoleamine dioxyge-nase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection. Transplantation 2008; 85: 1357.
41. Park SJ, Nakagawa T, Kitamura H, et al. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 2004; 173: 3844.
42. Hoentjen F, Sartor RB, Ozaki M, et al. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 2005; 105: 689.
43. Randow F, Syrbe U, Meisel C, et al. Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor beta. J Exp Med 1995; 181: 1887.
44. van der Poll T, Coyle SM, Moldawer LL, et al. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J Infect Dis 1996; 174: 1356.
45. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002; 4: 903.
46. Endo S, Sakamoto Y, Kobayashi E, et al. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. Proc Natl Acad Sci USA 2008; 105: 14515.
47. Medvedev AE, Lentschat A, Wahl LM, et al. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 2002; 169: 5209.
48. Ziegler-Heitbrock HW. Molecular mechanism in tolerance to lipo-polysaccharide. J Inflamm 1995; 45: 13.
49. Rahimi RA, Leof EB. TGF-beta signaling: A tale of two responses. J Cell Biochem 2007; 102: 593.
50. McCartney-Francis N, Jin W, Wahl SM. Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway. J Immunol 2004; 172: 3814.
51. Naiki Y, Michelsen KS, Zhang W, et al. Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem 2005; 280: 5491.
52. Louis H, Le Moine O, Peny MO, et al. Hepatoprotective role of inter-leukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gas-troenterology 1997; 112: 935.
53. Moreno C, Merino J, Vazquez B, et al. Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression. Scand J Immunol 2004; 59: 553.
54. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307: 538.